Sinopharm, the largest healthcare company in China, said its research and development of vaccines against the novel coronavirus has made substantial progress, while treatment supplies for the infection are also to be increased.
Slated to kick off on April 29, the 162-day expo is poised to impress an expected number of 16 million visitors from home and abroad with a huge collection of plants, flowers and eye-catching pavilions as well as ideas for green development.
Situated at the nation's technological and scientific innovation hub, private companies in Beijing are mainly in the internet, cultural and science industries.
Six subforums and two roundtable meetings were scheduled for the two-day event, with topics ranging from disseminating Chinese culture to innovation in international discourse.
Six months later, data from the US Census Bureau show that consumers have settled into a routine and are adjusting their spending habits. In August, grocery and beverage stores were down 1.2 percent month-over-month but up 8.3 percent this year compared with 2019.
Slovenia
重庆治不孕不育有什么方法
Sinopharm Group is speeding up development of a candidate vaccine for the novel coronavirus that causes COVID-19, with more milestones having been achieved by the Chinese State-owned pharmaceutical giant ahead of hoped-for mass production.
Smith said the cub is the culmination of decades of partnership between the National Zoo and its colleagues in China to study the animals.
Sitting in a wheelchair, she appeared much younger than she is.
So far, HeZhong has accumulated some 6 million registered users, of which 81,260 investors and 637,446 borrowers have participated in the loan transactions facilitated through its platform.